Long-term persistence of second-line biologics in psoriatic arthritis patients with prior TNF inhibitor exposure: a nationwide cohort study from the French health insurance database (SNDS).

Laura Pina Vegas,Léa Hoisnard, Léa Bastard,Emilie Sbidian,Pascal Claudepierre

RMD open（2022）

引用 0|浏览2

暂无评分

摘要

Overall, this real-life study shows low persistence for all biologics at 3 years in PsA patients previously exposed to a TNFi. However, persistence was higher with an IL-17i or IL-12/23i than a TNFi.

查看译文

关键词

arthritis, psoriatic,biological therapy,tumor necrosis factor inhibitors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要